论文部分内容阅读
20世纪由于吸烟所致的小细胞肺癌(Sclc)和其他类型肺癌一样发病率有所增加,其发病高峰男性70～74岁,女性在60～69岁。对老年(>65岁)Sclc仍存在的问题是能否耐受强烈联合化疗,能否和年轻患者一样延长生存期,本文作者回顾性分析了48例老年
In the 20th century, the incidence of small cell lung cancer (Sclc) caused by smoking increased compared with other types of lung cancer. The incidence peak was 70-74 years old for men and 60-69 years for women. The question remains as to whether the elderly (>65 years old) Sclc is still able to tolerate strong combination chemotherapy and can prolong survival as young patients. The authors retrospectively analyzed 48 elderly patients.